 Shares of Instil Bio Inc. TIL, 14.38 tumbled 35.1 in premarket trading on Monday after the company said it paused enrollment in clinical trials for two experimental cell therapies due to manufacturing issues. Instil said it had notified regulators, and the decision is not the result of a clinical hold. 